Raia Drogasil stock reports 18.3 percent revenue growth
Published on 10/07/2026 at 03:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRaia Drogasil (BRRADLACNOR0) posted 18.3 percent year-over-year growth in gross revenue to BRL 12.8 billion in Q2 2026, according to BTG Pactual. Adjusted net income increased 24 percent to BRL 424 million, giving the Brazilian pharmacy retailer a stronger earnings base as it expands its store and digital network.
Q2 growth reaches double digits
BTG Pactual said adjusted EBITDA before IFRS 16 rose 18 percent to BRL 1.02 billion in Q2 2026, with an 8.0 percent margin. Same-store sales increased 12.5 percent, while mature stores grew 10.9 percent, showing that the revenue advance extended beyond new locations.
The company ended June 2026 with 3,687 stores after 76 net openings during the quarter and 329 additions over 12 months, according to BTG Pactual. Digital sales grew 52 percent year over year to BRL 3.9 billion and represented 31 percent of retail revenue, strengthening the link between the store footprint and online demand.
BTG keeps BRL 30 target
On October 6, 2026, BTG Pactual listed Raia Drogasil among its preferred long-term retail names, with a buy recommendation and a BRL 30.00 price target. The target lies 40.85 percent above the BRL 21.30 reference price cited in the report, placing valuation and execution alongside growth as the main investor debate.
The report also cited a 330 to 350 store-opening guidance range for 2026 and identified GLP-1 products as a growth driver. The counter-factor is margin pressure from product mix, while digital competition may intensify in hygiene, beauty and online medicines.
Raia Drogasil stock gains 9.18 percent
Raia Drogasil stock closed at BRL 21.29 on B3 on October 5, 2026, up 9.18 percent on the session. The finance quote for October 7, 2026, showed a BRL 37.2 billion market capitalization and a latest price of BRL 21.27.
Raia Drogasil stock facts
- Company: Raia Drogasil S.A.
- ISIN: BRRADLACNOR0
- Ticker: RADL3
- Trading venue: B3
- Price (as of October 5, 2026): BRL 21.29, closing price
- Market capitalization: BRL 37.2 billion (as of October 7, 2026)
- Sector / Industry: Healthcare / Medical Pharmaceuticals
Upcoming dates for Raia Drogasil stock
- October 8, 2026: Shares trade ex-interest on equity
